Lupin Company Profile - Aug 19, 2011 by WrightReports


More Info
									Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   Lupin Ltd
                                                                                        440 Wheelers Farms Road
                                                                                        Milford, CT 06461 U.S.A.

  Figures in Indian Rupees

                                Wright Quality Rating:BAA20                                Key Data

   Lupin Limited is an India-based pharmaceutical company. The company produces a          Ticker:
   range of generic and branded formulations and Active Pharmaceutical Ingredients         500257
   (APIs). The Company's product basket consists of formulations from Cephalosporins,
   CVS, CNS, Anti-Asthma, Anti-TB, Diabetology, Dermatology, GI, and other therapy         2011 Sales:
   segments. The Company's drug delivery platforms include
   Bioadhesive/Gastroretentive Extended Release, Laser-Drilled Extended Release,
   Matrix/Coated Extended Release, Taste Masking Technologies and Improved
   Bioavailability through Solubilizationand Nano-particle technology. Its APIs products   Major Industry:
   include antibiotics, Antibiotics, ANTI-TB, Cardiovasculars, Central Nervous System,     Drugs, Cosmetics & Health
   Analegesics and ANTI-GOUT. As on March 31, 2011, the Company had 18                     Care
   subsidiaries. During the fiscal year ended March 31, 2011, the Company merged
   Novodigm with its API business.                                                         Sub Industry:
                       Stock Chart                                   Officers              Ethical Drug Manufacturers
                                                              Dr. Desh Bandhu Gupta        Country:
                                                              President & Executive
                                                                    Director               Currency:
                                                                   Nilesh Gupta
                                                                                           Indian Rupees

                                                           Executive Vice President
                                                                                           Fiscal Year Ends:
                                                                Sunil Makharia             March

                                                        Executive Managing Director Employees
                                                            Dr. Kamal K. Sharma     5,000

                                                                Secretary & Chief          Exchanges:
                                                               Compliance Officer          BOM
                                                               Rajvardhan V. Satam
                                                                                           Share Type:

           Stock Price (8/12/2011): 453.05
                                                                                           Market Capitalization:
To top